Approval · Notice of Compliance 2504 · 2001
PLAS+SD: Notice of Compliance 2504
Issued November 14, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2504
- Date
- November 14, 2001
- Company
- Precision Pharma Services, Inc.Melville, New York, United States
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Changes to the manufacturing method
- Therapeutic class
- Plasma component/derivative
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PLAS+SD | Not yet assigned | — |
Medicinal ingredients
- PLASMA PROTEIN FRACTION (HUMAN) 200 ML per PCK